ID: ALA1255708

Max Phase: Preclinical

Molecular Formula: C157H215N43O23

Molecular Weight: 3072.72

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)CC)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O

Standard InChI:  InChI=1S/C157H215N43O23/c1-5-95(3)133(199-136(205)110(162)75-97-43-14-7-15-44-97)153(222)189-116(64-35-39-71-161)143(212)197-128(84-106-88-170-93-180-106)151(220)194-125(81-103-55-26-13-27-56-103)152(221)200-134(96(4)6-2)154(223)198-129(85-107-89-171-94-181-107)150(219)188-119(67-42-74-174-157(168)169)144(213)191-121(77-99-47-18-9-19-48-99)137(206)179-91-131(202)177-90-130(201)178-92-132(203)182-122(78-100-49-20-10-21-50-100)145(214)185-113(61-32-36-68-158)138(207)183-114(62-33-37-69-159)141(210)192-124(80-102-53-24-12-25-54-102)147(216)196-126(82-104-86-175-111-59-30-28-57-108(104)111)148(217)186-115(63-34-38-70-160)142(211)195-127(83-105-87-176-112-60-31-29-58-109(105)112)149(218)193-123(79-101-51-22-11-23-52-101)146(215)187-117(65-40-72-172-155(164)165)139(208)184-118(66-41-73-173-156(166)167)140(209)190-120(135(163)204)76-98-45-16-8-17-46-98/h7-31,43-60,86-89,93-96,110,113-129,133-134,175-176H,5-6,32-42,61-85,90-92,158-162H2,1-4H3,(H2,163,204)(H,170,180)(H,171,181)(H,177,202)(H,178,201)(H,179,206)(H,182,203)(H,183,207)(H,184,208)(H,185,214)(H,186,217)(H,187,215)(H,188,219)(H,189,222)(H,190,209)(H,191,213)(H,192,210)(H,193,218)(H,194,220)(H,195,211)(H,196,216)(H,197,212)(H,198,223)(H,199,205)(H,200,221)(H4,164,165,172)(H4,166,167,173)(H4,168,169,174)/t95-,96-,110-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,133-,134-/m0/s1

Standard InChI Key:  VQZCIBCKDQUODZ-TXYJCSJXSA-N

Associated Targets(non-human)

Streptococcus mutans 2687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus sobrinus 228 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus sanguinis 314 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus mitis 390 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pseudomonas aeruginosa 123386 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus oralis 178 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus gordonii 131 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus salivarius 87 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 3072.72Molecular Weight (Monoisotopic): 3070.6976AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. He J, Yarbrough DK, Kreth J, Anderson MH, Shi W, Eckert R..  (2010)  Systematic approach to optimizing specifically targeted antimicrobial peptides against Streptococcus mutans.,  54  (5): [PMID:20211885] [10.1128/aac.01391-09]

Source